These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35393542)

  • 1. Aurora kinase A inhibition induces synthetic lethality in SMAD4-deficient colorectal cancer cells via spindle assembly checkpoint activation.
    Shi C; Tao S; Ren G; Yang EJ; Shu X; Mou PK; Liu Y; Dang Y; Xu X; Shim JS
    Oncogene; 2022 May; 41(19):2734-2748. PubMed ID: 35393542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells.
    Wu C; Lyu J; Yang EJ; Liu Y; Zhang B; Shim JS
    Nat Commun; 2018 Aug; 9(1):3212. PubMed ID: 30097580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression.
    Shi C; Yang EJ; Liu Y; Mou PK; Ren G; Shim JS
    Oncogene; 2021 Feb; 40(5):937-950. PubMed ID: 33293694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the
    Gong X; Du J; Parsons SH; Merzoug FF; Webster Y; Iversen PW; Chio LC; Van Horn RD; Lin X; Blosser W; Han B; Jin S; Yao S; Bian H; Ficklin C; Fan L; Kapoor A; Antonysamy S; Mc Nulty AM; Froning K; Manglicmot D; Pustilnik A; Weichert K; Wasserman SR; Dowless M; Marugán C; Baquero C; Lallena MJ; Eastman SW; Hui YH; Dieter MZ; Doman T; Chu S; Qian HR; Ye XS; Barda DA; Plowman GD; Reinhard C; Campbell RM; Henry JR; Buchanan SG
    Cancer Discov; 2019 Feb; 9(2):248-263. PubMed ID: 30373917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner.
    Jia L; Lee HS; Wu CF; Kundu J; Park SG; Kim RN; Wang LH; Erkin ÖC; Choi JS; Chae SW; Yang HB; Choi YL; Shin YK
    Mol Cancer Res; 2014 Dec; 12(12):1779-95. PubMed ID: 25061104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expression.
    Sun Y; Chen J; Hong JH; Xiao R; Teng Y; Wang P; Deng P; Yu Z; Chan JY; Chai KXY; Gao J; Wang Y; Pan L; Liu L; Liu S; Teh BT; Yu Q; Lim ST; Li W; Xu B; Ong CK; Tan J
    Oncogene; 2024 Jul; 43(28):2172-2183. PubMed ID: 38783101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer.
    Alcaraz-Sanabria A; Nieto-Jiménez C; Corrales-Sánchez V; Serrano-Oviedo L; Andrés-Pretel F; Montero JC; Burgos M; Llopis J; Galán-Moya EM; Pandiella A; Ocaña A
    Mol Cancer Ther; 2017 Nov; 16(11):2552-2562. PubMed ID: 28847989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora kinase A, a synthetic lethal target for precision cancer medicine.
    Mou PK; Yang EJ; Shi C; Ren G; Tao S; Shim JS
    Exp Mol Med; 2021 May; 53(5):835-847. PubMed ID: 34050264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
    Boos SL; Loevenich LP; Vosberg S; Engleitner T; Öllinger R; Kumbrink J; Rokavec M; Michl M; Greif PA; Jung A; Hermeking H; Neumann J; Kirchner T; Rad R; Jung P
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):517-540. PubMed ID: 34700030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer.
    Jacobsen A; Bosch LJW; Martens-de Kemp SR; Carvalho B; Sillars-Hardebol AH; Dobson RJ; de Rinaldis E; Meijer GA; Abeln S; Heringa J; Fijneman RJA; Feenstra KA
    Sci Rep; 2018 May; 8(1):7522. PubMed ID: 29760449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
    Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
    Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic lethality of RB1 and aurora A is driven by stathmin-mediated disruption of microtubule dynamics.
    Lyu J; Yang EJ; Zhang B; Wu C; Pardeshi L; Shi C; Mou PK; Liu Y; Tan K; Shim JS
    Nat Commun; 2020 Oct; 11(1):5105. PubMed ID: 33037191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmatine induces G2/M phase arrest and mitochondrial-associated pathway apoptosis in colon cancer cells by targeting AURKA.
    Liu X; Zhang Y; Wu S; Xu M; Shen Y; Yu M; Fan J; Wei S; Xu C; Huang L; Zhao H; Li X; Ye X
    Biochem Pharmacol; 2020 May; 175():113933. PubMed ID: 32224138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
    Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
    Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
    Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck.
    Lee JW; Parameswaran J; Sandoval-Schaefer T; Eoh KJ; Yang DH; Zhu F; Mehra R; Sharma R; Gaffney SG; Perry EB; Townsend JP; Serebriiskii IG; Golemis EA; Issaeva N; Yarbrough WG; Koo JS; Burtness B
    Clin Cancer Res; 2019 Jun; 25(11):3430-3442. PubMed ID: 30755439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of AURKA sensitizes the efficacy of radiation in human colorectal cancer.
    Liu F; Zhang Y; Dong Y; Ning P; Zhang Y; Sun H; Li G
    Life Sci; 2021 Apr; 271():119148. PubMed ID: 33545203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21
    Ren G; Chen J; Pu Y; Yang EJ; Tao S; Mou PK; Chen LJ; Zhu W; Chan KL; Luo G; Deng C; Shim JS
    Int J Biol Sci; 2024; 20(6):1978-1991. PubMed ID: 38617536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.
    Jiang Z; Jiang J; Yang H; Ge Z; Wang Q; Zhang L; Wu C; Wang J
    Oncol Rep; 2014 Mar; 31(3):1249-54. PubMed ID: 24452445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.